Global Perspectives on Gastrointestinal Malignancies in 2021 and Beyond

Expert perspectives and strategic insights on the latest therapeutic developments in gastrointestinal malignancies.

July 9 and 12, 2021
Gerald Prager MD Aptitude Health 2020 GI

Faculty Co-Chair

Gerald Prager, MD

Medical University of Vienna, Vienna, Austria

Howard Hochster, MD, FACP, Aptitude Health Scientific Leader

Faculty Co-Chair

Howard Hochster, MD, FACP

Rutgers Cancer Institute of New Jersey, Brunswick, NJ, USA


Dominik Modest, MD
Charité – Universitätsmedizin Berlin, Berlin, Germany

Eric Van Cutsem, MD, PhD
University of Leuven, Leuven, Belgium

Julien Taieb, MD, PhD
Université Paris Descartes, Paris, France

Teresa Macarulla, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Manish Shah, MD
Weill Cornell Medicine, New York, NY, USA

Tanios S. Bekaii-Saab, MD, FACP
Mayo Clinic Cancer Center, Phoenix, AZ

Efrat Dotan, MD
Fox Chase Cancer Center, Philadelphia, PA, USA

Sample Report

Start discovering the insights

View Report


  • Role of Immunotherapy and Targeted Agents in Gastroesophageal (GE) and Gastric Cancer
  • Integration and Sequencing of New Agents in Hepatocellular Carcinoma (HCC)
  • Treatment of Resectable Pancreatic Cancer and Metastatic Pancreatic Cancer
  • New Therapeutic Options in Biliary Tract Cancer
  • Metastatic Colorectal Cancer – Recent Insights and Future Approaches: Chemotherapy, Targeted Therapies, and Biomarker-Driven Treatments
  • Metastatic Colorectal Cancer – Recent Insights in Immunotherapy
  • Advances in Neoadjuvant Therapy for Rectal Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.